Logo image
Cytokine expression in murine cytomegalovirus-induced myocarditis: modulation with interferon-α therapy
Journal article   Peer reviewed

Cytokine expression in murine cytomegalovirus-induced myocarditis: modulation with interferon-α therapy

J.C. Lenzo, J.P. Mansfield, S. Sivamoorthy, V.S. Cull and C.M. James
Cellular Immunology, Vol.223(1), pp.77-86
2003
url
Link to Published Version *Subscription may be requiredView

Abstract

Cytomegalovirus-induced myocarditis is largely immune-mediated. BALB/c mice produced higher levels of IL-4 in the heart indicative of a Th2-like response. Although IL-6, IL-10, IL-18, and TNF-α were produced in the heart during acute infection, BALB/c mice lacked a substantial IL-2 and IFN-γ response. Conversely, C57BL/6 mice produced significant levels of IFN-γ in the heart with no significant levels of IL-4 or IL-6, suggestive of a dominant Th1-like response to virus infection. IFN-α/β immunotherapy is known to suppress the development of MCMV-myocarditis. Cytokine secretion in IFN-stimulated MCMV-infected BALB/c myocytes was found to be IFN subtype-dependent with elevation of IL-6 and IL-18 levels. During the chronic phase of disease, IFNA6 DNA treatment in vivo increased IL-18 production in the heart. These results suggest that IFN subtype therapy may have immunomodulating effects in reducing disease severity in BALB/c mice via regulation of cytokine production in the heart.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.37 Cardiology - General
1.37.1920 Myocarditis
Web Of Science research areas
Cell Biology
Immunology
ESI research areas
Immunology
Logo image